Diagnosis and surgical treatment of thoracic malignant lymphoma:a report for 22 cases
- VernacularTitle:胸部恶性淋巴瘤的诊断及手术疗效观察(附22例报告)
- Author:
Tao LIANG
;
Xueliang YANG
;
Yang LIU
- Publication Type:Journal Article
- Keywords:
lymphoma;
thoracic neoplasms;
diagnosis;
treatment outcome
- From:
Medical Journal of Chinese People's Liberation Army
1981;0(04):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the clinical features, diagnosis and surgical treatment of thoracic malignant lymphoma. Methods Clinical data of 22 patients with malignant lymphoma were retrospectively analyzed. Among them 16 were classified as non-Hodgkin's lymphoma (B cell lymphoma 12 cases and T cell lymphoma 4 cases), and 6 were classified as Hodgkin's lymphoma (nodular sclerosing lymphoma 5 cases and 1 case of mixed cellularity type lymphoma). Most of the tumors were located in anterior mediastinum or middle superior mediastinum, and 2 of the tumors located in upper left lung, another 2 located in upper right lung. Cough, stethocatharsis, chest distress and chest pain were the main clinical symptoms. Abnormal masses in mediastinum were seen on X ray film, occasionally with changes in lung. Before the operation, 4 cases were misdiagnosed depended on the results of intracranial puncture examination, and the other 18 cases were misdiagnosed as either lung cancer with mediastinal lymph nodes metastasis or thymoma based on the imaging findings. All patients received either total tumor resection or partial excision. After the operation, 16 cases with non-Hodgkin's lymphoma received CHOP chemotherapy (2 cases received radiotherapy and 2 cases received autologous hematopoietic stem cell transplantation after chemotherapy), 6 cases with Hodgkin's lymphoma received ABVD regimen (2 case received radiotherapy). Results Fourteen cases with non-Hodgkin′s lymphoma (2 cases for stage Ⅰ, 4 cases for stage Ⅱ, 3 cases for stage Ⅲ, 5 cases for stage Ⅳ) had survived for 1-112 months until the follow-up, 6 cases with Hodgkin′s lymphoma (2 cases for stage Ⅰ, 1 case for stage Ⅱ, 1 case for stage Ⅲ, 2 cases for stage Ⅳ) had survived for 3-46 months. Two cases with non-Hodgkin′s lymphoma died 18 and 35 months after operation, respectively. Conclusions The preoperative diagnosis to thoracic malignant lymphoma is difficult for the special clinical features limited. Surgical excision is important for diagnosis and treatment of thoracic malignant lymphoma. Comprehensive treatment after surgery includes radiotherapy, regular chemotherapy and immunotherapy.
